Related references
Note: Only part of the references are listed.Buprenorphine-cannabis interaction in patients undergoing opioid maintenance therapy
Christopher Vierke et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2021)
Respiratory depression following medications for opioid use disorder (MOUD)-approved buprenorphine product oral exposures; National Poison Database System 2003-2019
Michael A. Darracq et al.
CLINICAL TOXICOLOGY (2021)
Concomitant drugs with buprenorphine user deaths
Claudia Mariottini et al.
DRUG AND ALCOHOL DEPENDENCE (2021)
Characteristics and circumstances of death related to buprenorphine toxicity in Australia
Shane Darke et al.
DRUG AND ALCOHOL DEPENDENCE (2021)
Association Between Benzodiazepine or Z-Drug Prescriptions and Drug-Related Poisonings Among Patients Receiving Buprenorphine Maintenance: A Case-Crossover Analysis
Kevin Y. Xu et al.
AMERICAN JOURNAL OF PSYCHIATRY (2021)
Opioid Overdose Deaths with Buprenorphine Detected in Postmortem Toxicology: a Retrospective Analysis
Rachel S. Wightman et al.
JOURNAL OF MEDICAL TOXICOLOGY (2021)
ANSI/ASB Standard 036 for Method Validation in Forensic Toxicology Has Replaced SWGTOX's Version
Marc A. LeBeau
JOURNAL OF ANALYTICAL TOXICOLOGY (2020)
Mechanisms of QT prolongation by buprenorphine cannot be explained by direct hERG channel block
Phu N. Tran et al.
PLOS ONE (2020)
The Next Stage of Buprenorphine Care for Opioid Use Disorder Response
Stephen A. Martin et al.
ANNALS OF INTERNAL MEDICINE (2019)
Bupenorphine in Wisconsin Drivers: Concerns for Impairment?
Lorrine D. Edwards
JOURNAL OF ANALYTICAL TOXICOLOGY (2019)
Medication-Assisted Treatment for Opioid-Use Disorder
Tyler S. Oesterle et al.
MAYO CLINIC PROCEEDINGS (2019)
Buprenorphine Pharmacology Review: Update on Transmucosal and Long-acting Formulations
Marion A. Coe et al.
JOURNAL OF ADDICTION MEDICINE (2019)
The inhibitory effects of mitragynine on P-glycoprotein in vitro
Noradliyanti Rusli et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2019)
Norbuprenorphine and respiratory depression: Exploratory analyses with new lyophilized buprenorphine and sublingual buprenorphine
John Strang et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2018)
High buprenorphine-related mortality is persistent in Finland
Pirkko Kriikku et al.
FORENSIC SCIENCE INTERNATIONAL (2018)
Postmortem Toxicology of New Synthetic Opioids
Marta Concheiro et al.
FRONTIERS IN PHARMACOLOGY (2018)
Neurorespiratory Effects of Buprenorphine and Ethanol in Combination: A Mechanistic Study of Drug-Drug Interactions in the Rat
Camille Cohier et al.
TOXICOLOGICAL SCIENCES (2017)
P-gp/ABCB1 exerts differential impacts on brain and fetal exposure to norbuprenorphine
Michael Z. Liao et al.
PHARMACOLOGICAL RESEARCH (2017)
Effects of buprenorphine on QT intervals in healthy subjects: results of 2 randomized positive- and placebo-controlled trials
Stephen C. Harris et al.
POSTGRADUATE MEDICINE (2017)
Gabapentin, opioids, and the risk of opioid-related death: A population-based nested case-control study
Tara Gomes et al.
PLOS MEDICINE (2017)
Presence or Absence of QTc Prolongation in Buprenorphine-Naloxone Among Youth With Opioid Dependence
Sabrina A. Poole et al.
JOURNAL OF ADDICTION MEDICINE (2016)
Arrhythmia associated with buprenorphine and methadone reported to the food and drug administration
David P. Kao et al.
ADDICTION (2015)
Buprenorphine infrequently found in fatal overdose in New York City
Denise Paone et al.
DRUG AND ALCOHOL DEPENDENCE (2015)
Buprenorphine - an attractive opioid with underutilized potential in treatment of chronic pain
Ish K. Khanna et al.
JOURNAL OF PAIN RESEARCH (2015)
An Unusual Case of Death Probably Triggered by the Association of Buprenorphine at Therapeutic Dose with Ethanol and Benzodiazepines and with Very Low Norbuprenorphine Level
Guillaume Bardy et al.
JOURNAL OF FORENSIC SCIENCES (2015)
Potentiation of the Effect of Buprenorphine/Naloxone With Gabapentin or Quetiapine
Roy R. Reeves et al.
AMERICAN JOURNAL OF PSYCHIATRY (2014)
Buprenorphine maintenance and mu-opioid receptor availability in the treatment of opioid use disorder: Implications for clinical use and policy
Mark K. Greenwald et al.
DRUG AND ALCOHOL DEPENDENCE (2014)
Intravenous buprenorphine and norbuprenorphine pharmacokinetics in humans
M. A. Huestis et al.
DRUG AND ALCOHOL DEPENDENCE (2013)
Sleep disordered breathing in patients receiving therapy with buprenorphine/naloxone
Robert J. Farney et al.
EUROPEAN RESPIRATORY JOURNAL (2013)
Parenteral buprenorphine-naloxone abuse is a major cause of fatal buprenorphine-related poisoning
Margareeta Hakkinen et al.
FORENSIC SCIENCE INTERNATIONAL (2013)
Gabapentin and Diclofenac Reduce Opioid Consumption in Patients Undergoing Tonsillectomy: A Result of Altered CNS Drug Delivery?
Patrick T. Ronaldsonl et al.
ARCHIVES OF TRAUMA RESEARCH (2013)
Respiratory toxicity of buprenorphine results from the blockage of P-glycoprotein-mediated efflux of norbuprenorphine at the blood-brain barrier in mice
Hisham Alhaddad et al.
CRITICAL CARE MEDICINE (2012)
Polydrug abuse: A review of opioid and benzodiazepine combination use
Jermaine D. Jones et al.
DRUG AND ALCOHOL DEPENDENCE (2012)
Benzodiazepines and alcohol are associated with cases of fatal buprenorphine poisoning
Margareeta Hakkinen et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2012)
Toxicological and pathological findings in a series of buprenorphine related deaths. Possible risk factors for fatal outcome
Tor Selden et al.
FORENSIC SCIENCE INTERNATIONAL (2012)
Prescription opioid abuse, chronic pain, and primary care: A Co-Occurring Disorders Clinic in the chronic disease model
Patricia A. Pade et al.
JOURNAL OF SUBSTANCE ABUSE TREATMENT (2012)
P-Glycoprotein Is a Major Determinant of Norbuprenorphine Brain Exposure and Antinociception
Sarah M. Brown et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
The pharmacodynamic and pharmacokinetic profile of intranasal crushed buprenorphine and buprenorphine/naloxone tablets in opioid abusers
Lisa S. Middleton et al.
ADDICTION (2011)
Buprenorphine Metabolites, Buprenorphine-3-glucuronide and Norbuprenorphine-3-glucuronide, Are Biologically Active
Sarah M. Brown et al.
ANESTHESIOLOGY (2011)
Fatal poisoning due to snorting buprenorphine and alcohol consumption
Ophelie Ferrant et al.
FORENSIC SCIENCE INTERNATIONAL (2011)
Buprenorphine-related deaths: unusual forensic situations
Anne-Laure Pelissier-Alicot et al.
INTERNATIONAL JOURNAL OF LEGAL MEDICINE (2010)
Interaction of drugs of abuse and maintenance treatments with human P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2)
Nicolas Tournier et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2010)
Opioids and the control of respiration
K. T. S. Pattinson
BRITISH JOURNAL OF ANAESTHESIA (2008)
Drugs behave as substrates, inhibitors and inducers of human cytochrome P450 3A4
Shu-Feng Zhou
CURRENT DRUG METABOLISM (2008)
Assessment of antiepileptic drugs as substrates fair canine P-glycoprotein
Chadwick L. West et al.
AMERICAN JOURNAL OF VETERINARY RESEARCH (2007)
Pharmacokinetic-pharmacodynamic modeling of the respiratory depressant effect of norbuprenorphine in rats
Ashraf Yassen et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
A survey of buprenorphine related deaths in Singapore
Siang Hui Lai et al.
FORENSIC SCIENCE INTERNATIONAL (2006)
Characterization of P-glycoprotein inhibition by major cannabinoids from marijuana
HJ Zhu et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Buprenorphine induces ceiling in respiratory depression but not in analgesia
A Dahan et al.
BRITISH JOURNAL OF ANAESTHESIA (2006)
Role of NMDA receptors in development of respiratory control
KA Waters et al.
RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY (2005)
The effect of buprenorphine and benzodiazepines on respiration in the rat
S Nielsen et al.
DRUG AND ALCOHOL DEPENDENCE (2005)
Effect of benzodiazepines on the metabolism of buprenorphine in human liver microsomes
Y Chang et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2005)
Bluprenorphine - Clinical pharmacokinetics in the treatment of opioid dependence
A Elkader et al.
CLINICAL PHARMACOKINETICS (2005)
A critical review of the causes of death among post-mortem toxicological investigations: analysis of 34 buprenorphine-associated and 35 methadone-associated deaths
S Pirnay et al.
ADDICTION (2004)
Effects of high-dose intravenous buprenorphine in experienced opioid abusers
A Umbricht et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2004)
Pharmacokinetics and subjective effects of sublingual buprenorphine, alone or in combination with naloxone - Lack of dose proportionality
DS Harris et al.
CLINICAL PHARMACOKINETICS (2004)
Serious overdoses involving buprenorphine in Helsinki
J Boyd et al.
ACTA ANAESTHESIOLOGICA SCANDINAVICA (2003)
Inhibition of P-glycoprotein by newer antidepressants
J Weiss et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Influence of opioid agonists on cardiac human ether-a-go-go related gene K+ currents
AN Katchman et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Deaths involving buprenorphine: a compendium of French cases
P Kintz
FORENSIC SCIENCE INTERNATIONAL (2001)
Share Paper
